Clicky

Nuwellis, Inc.(NUWE) News

Date Title
Nov 11 Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
Nov 5 Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
Jul 26 Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s
Jul 24 Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules
Jul 23 Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024
Jul 17 Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
Jun 26 Nuwellis Announces Reverse Stock Split
Jun 25 Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™
Apr 26 Nuwellis Announces Pricing of $2.7 Million Public Offering
Nov 28 New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients
Nov 14 Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)